Johnson & johnson
JNJ 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分較低，不過公司股利評分優異，若想穩定收息，仍可以考慮持續持有。但若僅以價值投資為目標可以減碼換股操作
JNJ 近期報酬表現
0.67%
Johnson & johnson
-0.98%
同產業平均
-0.22%
S&P500
與 JNJ 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
GSK | Gsk plc | 3 分 | 2 分 | 2 分 | 2 分 | 5 分 | |
NVS | Novartis ag | 3 分 | 1 分 | 2 分 | 2 分 | 5 分 | |
ABBV | Abbvie inc | 4 分 | 2 分 | 1 分 | 3 分 | 5 分 | |
AMGN | Amgen inc | 3 分 | 2 分 | 2 分 | 3 分 | 5 分 | |
BMY | Bristol-myers squibb company | 4 分 | 2 分 | 1 分 | 2 分 | 5 分 |
- GSK Gsk plc價值 3 分趨勢 2 分波段 2 分籌碼 2 分股利 5 分查看更多
JNJ 公司資訊
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, and vision fields. These products are distributed to wholesalers, hospitals, and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.